Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Endosc. May 16, 2023; 15(5): 407-419
Published online May 16, 2023. doi: 10.4253/wjge.v15.i5.407
Figure 1
Figure 1 Flow diagram of patient selection. IBD: Inflammatory bowel disease; EoE: Eosinophilic esophagitis.
Figure 2
Figure 2 Wilcoxon rank-sum test to assess fractional exhaled nitric oxide levels in eosinophilic esophagitis group compared to control. FeNO: Fractional exhaled nitric oxide; EoE: Eosinophilic esophagitis.
Figure 3
Figure 3 Receiver operating characteristics analysis to predict fractional exhaled nitric oxide cut off. ROC: Receiver operating characteristics; FeNO: Fractional exhaled nitric oxide; EoE: Eosinophilic esophagitis.
Figure 4
Figure 4 Spearman correlation analysis between fractional exhaled nitric oxide and esophageal eosinophils. FeNO: Fractional exhaled nitric oxide; eos: Eosinophils.